← Open Payments lookup

TROY CARR: Open Payments

NPI 1275250102 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,223 in 74 payments from 14 companies in 2025. Trend: 2023 $1,233 · 2024 $1,425 · 2025 $1,223

Food & beverage: $1,223
CompanyPaymentsAmount
ABBVIE INC.39$405
Madrigal Pharmaceuticals8$213
GENZYME CORPORATION6$129
GlaxoSmithKline, LLC.1$95
Regeneron Healthcare Solutions, Inc.4$78
Takeda Pharmaceuticals U.S.A., Inc.3$64
PFIZER INC.4$63
Aimmune Therapeutics, Inc.2$41
Celltrion USA Inc.2$34
Janssen Biotech, Inc.1$28

Products named: RINVOQ, REZDIFFRA, DUPIXENT, SKYRIZI, VELSIPITY, CREON, ZENPEP, ENTYVIO.

Industry payments across ID — which companies pay providers there.